G2 2AB (500pmol/vial)1vial

4-Phenylbut-3-yn-2-one, 95.0%, 25g

tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-imidazole-1-carboxylate, 97%, 250mg

Spiro[adamantane-2,9'-fluorene], 98%, 25g

(R)-2-Methyltetrahydrofuran-2-carboxylic acid, 98%, 500mg

4,5-Difluoroindolin-2-one, 95.0%, 1g

(R)-3-((((9h-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(m-tolyl)propanoic acid, 95+%, 1g

5,7-DICHLOROPYRIDO[3,4-B]PYRAZINE, 95.0%, 1g

Lanthanum oxide powder 99.99% 250 g

3-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 97.0%, 1g

METHYL 6-METHYL-5-NITROPICOLINATE, 95.0%, 1g

2-ETHYLANISOLE, 95%, 25g

4-(4-Methoxyphenyl)-1-butanol, 98.0%, 5g